Chatterjee Laboratory

03/08/2025

I’ve just returned from an inspiring visit to Europe, where I had the opportunity to strengthen collaborations with leading researchers and institutions working at the forefront of epigenetics and disease.
This visit was an excellent chance to exchange ideas on translational epigenetics, biomarker discovery, and liquid biopsy innovations — areas that have the potential to transform cancer diagnostics and precision medicine and topics that our research group is playing a lead role in Aotearoa New Zealand
I’m grateful for the warm welcome and engaging discussions with old and new friends and colleagues across multiple countries and labs in Europe, whose work continues to push boundaries in our field. These connections are crucial as we work towards building robust international networks that will accelerate impactful research and deliver real benefits for patients. I also believe that in today's interconnected world and constrained environment, collaboration is more important than ever to maximise the potential of our research and achieve better outcomes.
Looking forward to continued collaboration and hopefully many exciting joint projects ahead! (including hopefully Horizon EU projects).
hashtag hashtag hashtag hashtag hashtag

28/07/2025

Our new research journey (excited, motivated and emotional) in pancreatic cancer starts. There is no word to express my gratitude and thanks to the Louise Davie Charitable Trust for the support and funding. We have a great team and we will leave no stone unturned to achieve the outcome. Thanks to Otago Daily times (Otago Daily Times) for this article. Health Sciences at Otago Department of Pathology, University of Otago Otago Medical Research Foundation

Dunedin researchers are heading up an international study to identify abnormal DNA markers in order to detect a deadly cancer before it is too late...

26/05/2025

Chatterjee Lab's New Lab Poster 2025. I am very privileged to lead this wonderful group. Big thanks to Euan Rodger for his Magic skills in making the poster. Thanks to Sayan for his input as well.

18/05/2025

Our paper on Application of DNA Methylome Analysis to Patients with ME/CFS is now out.

Myalgic encephalomyelitis/chronic fatigue syndrome is a post-viral/stressor syndrome that has a complex pathophysiology reflecting multiple changes in many cell transcripts and proteins. These changes imply a change in the regulation of gene expression at the level...

19/03/2025

Supervising students and training the next generation of scientists is truly one of the biggest joys of my life and it is very humbling to get recognised for it by UKCGE (UK Council for Graduate Research). Thank you.

https://www.otago.ac.nz/news/newsroom/dsm-supervisors-top-notch-skills-recognised?fbclid=IwY2xjawJHR5BleHRuA2FlbQIxMQABHXFVu4O9vuggfOXdChh4_EmX8f2s8WJHZi8nfU3waFSzqkLC_YDGvGV29Q_aem_OksQL20HFIxcOZBXk9hGIw

A Dunedin School of Medicine researcher has been recognised internationally for his sterling supervision of postgraduate students.

19/02/2025

Pleased to be listed in the top 0.05% of scientists worldwide in the field of methylation. Thanks to Otago Medical School, University of Otago for the story and Department of Pathology, University of Otago for the support.

https://www.facebook.com/share/p/18aqRikTwG/

Associate Professor Aniruddha Chatterjee from the Dunedin School of Medicine has been ranked in the top 0.05% of scientists worldwide in the field of methylation.

According to scholarly analytics platform ScholarGPS, in this area of research Aniruddha, of the Department of Pathology, is ranked 31 in the world and is the only representative from New Zealand and Australia at that level.

Aniruddha, whose research focuses on epigenetic changes in different cellular contexts to achieve a better understanding of cancer, says he is delighted to be recognised in this way.

Methylation is a biochemical process in which a small molecule called a methyl group is added to DNA, proteins or other molecules.
Department of Pathology, University of Otago

08/12/2024

Last 2 weeks or so has been busy, intense, fun and a total buzz for us with science, colleagues, community in Dunedin. I was delighted to host long-term collaborator and friend Prof. Frederic Silvestre from the University of Namur, Belgium (https://lnkd.in/gC4-ri5z) in our lab in Dunedin (his first visit to NZ). Then with a great team, we were also able to host a very successful international meeting. The 10th Australasian Epigenetics Alliance meeting from 1-5 December (https://www.aepia.org.au/). We hosted colleagues from around the world, which led to many possibilities and collaborations. The lab also received 2 best talk awards in a week (one from AEpiA conference and one from the department, Mark Ezegbogu) Looking forward to see what 2025 brings. Kia ora. Department of Pathology, University of Otago Otago Medical School, University of Otago University of Otago

21/11/2024

Our lab group and collaborators had an amazing whakawhanaungatanga (the process of establishing relationships) and Wānanga (process of learning and sharing) with Karienne Hill (Te Aupōuri) to discuss and reflect on Te ao Māori and Māori engagement in our mahi on epigenetics and disease. It was a wonderful experience for all (particularly students) in a safe and beautiful whare in Dunedin. The korero and singing the waiata were amazing. Extremely grateful to Karienne (she came from Auckland for this mahi) and Safia. We are very excited and looking forward to doing our mahi to contribute research to improve patient outcomes and keep building together. Ngā mihi. Department of Pathology, University of Otago

17/11/2024

We are excited to start this new line of work which we have been working on in the background for a while. Very thankful to the Cancer Research Trust for the support.
https://www.facebook.com/OMSOtago/posts/pfbid02jSHvBCU8uZFpxq5uqm2n1zJGbDcS6xMTZbnu4AsKRa8fma5UwZEYjHxWaF5WUEfJl?rdid=VmpdzDBCoRo5E5Yu Department of Pathology, University of Otago

07/11/2024

Very proud of Dr Jim Smith to obtain the prestigious national fellowship (Roche Translational Researcher Award of 2024) and this will help us to further our work to develop tools to improve the diagnosis and management of prostate cancer. Department of Pathology, University of Otago University of Otago New Zealand Society for Oncology

A recently awarded prestigious national fellowship will help an Otago researcher further his work to improve the diagnosis and management of prostate cancer.

06/11/2024

We are seeking a highly motivated student with very high GPA preferably with knowledge of the following areas: bioinformatics, machine learning, and artificial intelligence (see advert below)

Come and work with us at Beautiful University of Otago at the Department of Pathology, University of Otago in Dunedin NZ

https://www.findaphd.com/phds/project/bioinformatic-cancer-epigenetics-phd-project/?p169661

Looking forward to see applications.
Thanks a lot,
Aniruddha and Euan.

PhD Project - Bioinformatic Cancer Epigenetics PhD project at University of Otago, listed on FindAPhD.com

13/09/2024

It is extremely rare for a bioinformatic tool to be used, maintianed and thrive for decades despite being published in prestigious journals (such as Nature etc and the tool doesnt work/not maintained after publication anymore). So it is amazing to see DMAP2 being maintained and updated and published again in an excellent journal. The original developments of these methods were first in the field and were published in Chatterjee and Stockwell et al NAR 2012 and Stockwell and Chatterjee et al Bioinformatics 2014 (From Ian Morison’s lab at that time). The papers now have>270 citations so far (Google Scholar) and after a decade updated DMAP2 has now got published. This demonstrates the tremendous dedication and passion shown by Dr Peter Sockwell to work on these tools, maintain them actively and help the community to use them for decades. Kudos to Dr Peter Stcokwell.

DNA methylation is well-established as a major epigenetic mechanism that can control gene expression and is involved in both normal development and disease. Analysis of high-throughput-sequencing-bas...